• Skip to primary navigation
  • Skip to main content
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • ESG Policy
  • Contact

Evotec

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • ESG Policy
  • Contact

News · November 10, 2011

Nine months results: Upside materialising

- Discovery Alliance Business Reports profitable Growth with Revenues up 54% and a positive operating result of € 9.5 m - Strong Q3 propelled by significant new product Partnering with Roche Hamburg, …

News · September 5, 2011

Evotec and Roche agree to develop compound that could slow the progression of Alzheimer's disease

Hamburg, Germany - 5 September 2011: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) and Roche AG (SIX: RO, ROG; OTCQX: RHHBY) announced today that they have entered into an exclusive worldwide …

News · July 7, 2011

Evotec AG – Multi-target collaboration with UCB in neurodegenerative and neurological diseases announced

Hamburg, Germany -7 July 2011: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today announced that it has entered into a three year integrated drug discovery collaboration with UCB to identify …

News · June 27, 2011

Milestone in an Ion Channel Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd. achieved

Evotec receives a milestone payment from Ono for the progression of novel ion channel modulators into lead optimization Hamburg, Germany -27 June 2011: Evotec AG (Frankfurt Stock Exchange: EVT, …

News · June 24, 2011

Evotec and Roche to jointly develop biomarkers in oncology

An alliance for personalized healthcare in cancer Research and Development Hamburg, Germany and Basel, Switzerland - 24 June 2011: Evotec AG (FSE: EVT, TecDAX) and Roche (SIX: RO, ROG; OTCQX: RHHBY) …

News · June 6, 2011

Evotec AG – Medicinal Chemistry Collaboration with Active Biotech

Hamburg, Germany - 6 June 2011: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today announced that it has entered into a medicinal chemistry collaboration with Active Biotech AB (NASDAQ OMX: …

News · May 25, 2011

Evotec and PsychoGenics Enter into a Strategic Alliance to Provide Integrated CNS Drug Discovery Solutions

Hamburg, Germany - 25 May 2011: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today announced that it has entered into a strategic alliance with PsychoGenics Inc. to provide integrated CNS drug …

News · May 12, 2011

Evotec reports 54% Q1 revenue growth and significant expansion of drug discovery alliance business

Hamburg, Germany - 12 May 2011: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today reported financial results and corporate updates for the first quarter of 2011. · Strong Q1 growth; …

News · March 24, 2011

Evotec AG – Full-Year 2010 Results: A good year with a strong start into 2011

Full-Year 2010 Results: A good year with a strong start into 2011 Hamburg, Germany - 24 March 2011: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today reported financial results and corporate …

News · March 10, 2011

Evotec Establishes Research Collaboration With Harvard University and the Howard Hughes Medical Institute in Diabetes Research

Collaboration Established to Drive Innovation and Develop New Diabetes Therapies Targeting Beta Cell Regeneration Hamburg, Germany, 10 March 2011: Evotec AG (TecDax: EVT) today announced the …

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

  • in

Copyright © 2023 · TVM Capital Life Science Venture Capital · ESG Disclosure · Privacy Policy · Contact